|Nasal covid vaccine|
Bharat Biotech,Indian Covaxin vaccine manufacturing company will conduct a trial on nasal vaccine against covid19.
prior to 3rd wave this study will be of big help: sources said.The study will tell us clearly in which mix the antibodies will remain longer.
The study will be done in 4 groups.
- Group A: This group will get both traditional injectable vaccine
- Group B: This group will get first dose as traditional injectable vaccine and second dose will be nasal vaccine
- Group C: This group will get the first dose as nasal and the second dose as injectable
- Group D: This group will get both the dose as nasal.
“We will do a comparative study of antibody level in all 4 groups.This will let us know which mix will give better results” Dr Gillurkar said.